Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

10 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   Brivaracetam   Brivaracetam   D08879   [1] SV2A   [1] ECM-receptor interaction   [2]
149,
309 
 2   Brivaracetam 25 mg   Brivaracetam   D08879   [1] SV2A   [1] ECM-receptor interaction   [1]
309 
 3   Brivaracetam 50 mg   Brivaracetam   D08879   [1] SV2A   [1] ECM-receptor interaction   [1]
309 
 4   Brv 2.5 mg   -   -   -   -   [1]
309 
 5   Brv 25 mg   -   -   -   -   [1]
309 
 6   Brv 50 mg   -   -   -   -   [1]
309 
 7   Intravenous immunoglobulin   Immune globulin human   -   -   -   [16]
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 8   Requip   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
309 
 9   Ropinirole   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [3]
6,
74,
309 
 10   Ropinirole hydrochloride   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
309